WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC

Go back to WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC
Danaher Corp. (NYSE: DHR) Delayed: 215.84 --0 (-0%)
Previous Close $215.84    52 Week High $102.79 
Open $215.84    52 Week Low $75.71 
Day High $215.84    P/E 56.80 
Day Low $215.84    EPS $3.80 
Volume 1,159